1 |
Golub LM, McNamara TF, Ryan ME et al. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001;28: 146-156
DOI
ScienceOn
|
2 |
Smith GN Ir, Mickler EA, Hasty KA, Brandt KD. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of thc enzyme. Arthritis Rheum 1999;42:1140-1146
DOI
ScienceOn
|
3 |
Position paper. Systemic antibiotics in periodontics. J Periodontol 2004;75:1553-1565
DOI
PUBMED
|
4 |
Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996; II :266-273
DOI
ScienceOn
|
5 |
Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64(Suppl. 5):432-444
PUBMED
|
6 |
Jeong SN, Han SB. The effects of low dose doxycycline regimen on gingival crevicular fluid enzyme activity of diabetic patients with periodontitis and adult periodontitis patients. J Korean Acad Periodontol 1997;27:701-722
DOI
|
7 |
Socransky SS, Smith C, Martin L et al. 'Checkerboard' DNA-DNA hybridization. Biotechniques 1994;17:788-792
PUBMED
|
8 |
Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: a review. Crit Rev Oral Bioi Med 1993;4:197-250
DOI
|
9 |
Birkedal-Hansen H. Role of cytokine and inflammatory mediators in tissue destruction. J Periodontal Res 1993;28: 500-510
DOI
PUBMED
ScienceOn
|
10 |
Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol 1996;3:85-96
PUBMED
|
11 |
Newman HN. Modes of application of anti-plaque chemicals. J Clin Periodontol 1986; 13:965-974
DOI
PUBMED
|
12 |
Golub LM, Wolff M, Lee HM et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodontal Res 1985;20:12-23
DOI
PUBMED
|
13 |
Thomas J, Walker C, Bradshaw M. Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility. J Periodontol 2000;71: 1472-1483
DOI
ScienceOn
|
14 |
Reynolds H, Mashimo P, Slot J et al. Use of tetracycline in the treatment of periodontitis. II. Microbiological studies. J Dent Res 1978;57:267
|
15 |
Golub LM, Ciancio SG, Ramamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res 1990;25:321-330
|
16 |
Caton JG, Ciancio SG, Blieden TM et al. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 2000;71:521-532
DOI
ScienceOn
|
17 |
Newman MG, Takei HH, Klokkevold PR, Carranza FA. Carranza's Clinical Periodontology, 10th ed. Philadelphia: W.B. Saunders; 2006:813-827
|
18 |
Dongari-Bagtzoglou AI, Ebersole JL. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodontal Res 1996;31:90-98
DOI
PUBMED
|
19 |
Howell TH, Williams RC. Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression. Crit Rev Oral Bioi Med 1993;4:177-196
DOI
|
20 |
Williams RC, Jeffcoat MK, Howell TH et al. Three year trial of flurbiprofen treatment in humans: post-treatment period. J Dent Res 1991;70:468
|
21 |
Thomas JG, Metheny RJ, Karakiozis JM, Wetzel 1M, Crout RJ. Long-term sub-antimicrobial doxycycline(Periostat) as adjunctive management in adult periodontitis: effects on subgingival bacterial population dynamics. Adv Dent Res 1998;12:32-39
DOI
ScienceOn
|
22 |
Golub LM, Sorsa T, Lee HM ct al. Doxycycline inhibits neutrophil(PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 1995;22: 100-109
DOI
PUBMED
ScienceOn
|
23 |
Genco RJ. Host responses in periodontal diseases: current concepts. J Periodontol 1992;63(Suppl. 4):338-355
DOI
PUBMED
|
24 |
Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis. J Clin Periodontol 1981 ;8:57 -72
DOI
PUBMED
|
25 |
Greenstein G. Local drug delivery in the treatment of periodontal diseases: Assessing the clinical significance of the results. J Periodontol 2006;77 :565-578
DOI
PUBMED
ScienceOn
|
26 |
Olsvik B, Tenover F. Tetracycline resistance in periodontal pathogens. Clin 1nfecta Dis 1993;16(Suppl. 4):310-323
DOI
ScienceOn
|
27 |
Lee JY, Lee YM, Shin SY et al. Effect of subantimicrobial dose doxycycline as an effective adjunct to scaling and root planing. J Periodontol 2004;75:1500-1508
DOI
ScienceOn
|
28 |
Heijl L, Dahlen G, Sundin Y, Wenader A, Goodson JM. A 4-quadrant comparative study of periodontal treatment using tetracycline containing drug delivery fibers and scaling. J Clin Periodontol 1991;18:111-116
DOI
PUBMED
|
29 |
Slots J, Rams TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol 1990; 17: 479-493
DOI
PUBMED
|
30 |
Kim YS, Paik JW, Kim CS, Choi SII, Kim CK. Clinical effect of the subantimicrobial dose of doxycycline(SDD) on the chronic periodontitis. J Korean Acad Periodontol 2002;32:415-425
DOI
|
31 |
Ciancio S, Ashley R. Safety and efficacy of sub-antimicrobial- dose doxycycline therapy in patients with adult periodontitis. Adv Dent Res 1998;12:27-31
DOI
ScienceOn
|